Japan should initiate the discussion on voluntary assisted dying legislation now.

Japan should initiate the discussion on voluntary assisted dying legislation now.
复制标题

DOI:
10.1186/s12910-023-00886-0
复制
发表时间:
2023-02-01
期刊:
影响因子:
2.7
通讯作者:
Fukuyama, Miki
Fukuyama, Miki
中科院分区:
人文科学2区
文献类型:
--
作者:
Asai, Atsushi;Okita, Taketoshi;Shimakura, Yoko;Tanaka, Masashi;Fukuyama, Miki

文献摘要

参考文献

相似文献

在日本,没有法律或官方指南管理自愿协助死亡(VAD)。关于终止维持生命措施的立法法案由于遭到强烈反对而未能提交国会,因此尚未提交审议。然而,日本最近发生了几起涉及VAD的案件。在此背景下,我们认为日本应该参照2017年在澳大利亚维多利亚省制定的《2017年自愿协助死亡法》(VADA 2017),开始讨论VAD立法。VADA 2017制定了广泛的严格保障措施,被认为是全球最安全和最保守的政策,医生根据患者的预谋要求提供协助死亡。我们考虑社会上对VADA 2017的反对意见。其中将包括反对VAD本身的论点,反对该法案有效性的论点,以及甚至反对启动VAD对话的意见。我们的结论是,为了保护那些处于弱势地位的人的生命权,同时尊重那些因无法忍受的痛苦而希望立即死亡的人的决策,对话必须立即开始,引入一项比VADA 2017更保守的政策,该政策坚定地考虑了反对VAD的论点。
No laws or official guidelines govern voluntary assisted dying (VAD) in Japan. A legislative bill on the termination of life-sustaining measures has yet to be sent to deliberations for legislation, due to strong opposition that has prevented it from being submitted to the Diet. However, Japan has recently witnessed several cases involving VAD. Against this backdrop, we argue that Japan should begin discussion on VAD legislation, referring to the Voluntary Assisted Dying Act 2017 (VADA2017), which was established in 2017 in Victoria, Australia. VADA2017 puts in place a wide range of stringent safeguards and is considered worldwide to be the safest and most conservative policy on a physician offering assisted dying based on the patient’s premeditated request. We consider what opposing opinions from society would arise in response to the VADA2017. Among these will include arguments against VAD itself, those against the validation of this act, and opinions that oppose even the initiation of the dialogue on VAD. We conclude that to protect the right to life among those placed in vulnerable positions and, at the same time, to respect decision-making of those who wish for immediate death due to unbearable suffering, the dialogue must immediately begin with that on introducing a policy more conservative than that of the VADA2017, which solidly considers arguments against VAD.
DOI: 10.1186/s12910-018-0251-z
发表时间: 2018-02-27
期刊: BMC medical ethics
影响因子: 2.7
作者:
Asai A;Masaki S;Okita T;Enzo A;Kadooka Y
通讯作者: Kadooka Y
DOI: 10.1016/j.healthpol.2021.09.003
发表时间: 2021-10-23
期刊: HEALTH POLICY
影响因子: 3.3
作者:
Close, Eliana;Willmott, Lindy;White, Ben P.
通讯作者: White, Ben P.
DOI: 10.1007/s41649-021-00191-1
发表时间: 2022-01
影响因子: 2.9
作者:
Asagumo A
通讯作者: Asagumo A
DOI: 10.1097/md.0000000000022743
发表时间: 2020-10-30
期刊: Medicine
影响因子: 1.6
作者:
Groenewoud AS;Sasaki N;Westert GP;Imanaka Y
通讯作者: Imanaka Y
DOI: 10.1007/s41649-021-00201-2
发表时间: 2022-04
影响因子: 2.9
作者:
Asai A;Okita T;Bito S
通讯作者: Bito S